U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2775127751Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCINot yet recruitingNo Results AvailableAcute Coronary SyndromeDrug: Ticagrelor|Drug: clopidogrel|Drug: Aspirin|Procedure: PCIhttps://ClinicalTrials.gov/show/NCT02201667
2775227752Comparison Study of the Effectiveness of Endobronchial Ultrasound Transbronchial Aspiration (EBUS-TBNA) Preformed With and Without an Inner Stylet in the Biopsy NeedleRecruitingNo Results AvailableInterstitial Lung DiseaseOther: EBUS without stylethttps://ClinicalTrials.gov/show/NCT02201654
2775327753Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical TrialActive, not recruitingNo Results AvailableReversible Pulpitis (Inflammation of the Nerve of the Tooth That Does Not Require Root Canal Treatment).Radiation: Cone Beam computed tomography (Morita Accuitomo)|Radiation: Periapical radiographshttps://ClinicalTrials.gov/show/NCT02201641
2775427754Correlation of Nasopharyngeal (NP) and Lower Oesophageal (LO) Temperatures in Ventilated ChildrenRecruitingNo Results AvailableChildDevice: Nasopharyngeal and oesophageal temperature probeshttps://ClinicalTrials.gov/show/NCT02201628
2775527755The Effect of Perineal Massage in ChildbirthCompletedNo Results AvailableObstetric Labor ComplicationsOther: Perineal massage in childbirthhttps://ClinicalTrials.gov/show/NCT02201615
2775627756Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over StudyRecruitingNo Results AvailableDiabetesDrug: Gliclazide|Drug: Glibenclamidehttps://ClinicalTrials.gov/show/NCT02201602
2775727757Feasibility of Endovascular Repair Of Ascending Aortic PathologiesRecruitingNo Results AvailableAortic Dissection|Intramural Hematoma|Penetrating Ulcer|PseudoaneurysmDevice: Endovascular repair with Valiant PS-IDE Stent Grafthttps://ClinicalTrials.gov/show/NCT02201589
2775827758Bortezomib in Rejection of Kidney TransplantsRecruitingNo Results AvailableChronic Antibody-mediated Transplant RejectionDrug: Bortezomib|Drug: Plasma exchanges and intravenous immunoglobulinshttps://ClinicalTrials.gov/show/NCT02201576
2775927759Minocycline Therapy for Management of Adverse Radiation EffectsNot yet recruitingNo Results AvailableIrradiation; Adverse EffectDrug: Minocyclinehttps://ClinicalTrials.gov/show/NCT02201563
2776027760Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With LiraglutideCompletedNo Results AvailableType 2 Diabetes Mellitushttps://ClinicalTrials.gov/show/NCT02201550
2776127761Kidney Disease and Ultrasound ImagingRecruitingNo Results AvailableRecipient of Kidney TransplantDevice: renal echographyhttps://ClinicalTrials.gov/show/NCT02201537
2776227762Study to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisRecruitingNo Results AvailablePlaque PsoriasisDrug: PF-04965842|Drug: PF-04965842|Drug: PF-04965842|Other: Placebohttps://ClinicalTrials.gov/show/NCT02201524
2776327763A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed ConditionsCompletedNo Results AvailableHealthyDrug: 3 mg PF-06412562 MR tablets_Fasted|Drug: 2 x 15 mg PF-06412562 MR tablets_Fasted|Drug: 2 x 15 mg PF-06412562 MR tablets_Fed|Drug: 10 mg PF-06412562 IR tabletshttps://ClinicalTrials.gov/show/NCT02201511
2776427764Randomized Clinical Trial for Primary Molar Pulpotomy, Biodentine Vs Formocresol-ZOENot yet recruitingNo Results AvailableDeep Dental CariesProcedure: Pulpotomies with Formocresol/OZE and Biodentinehttps://ClinicalTrials.gov/show/NCT02201498
2776527765Budd-Chiari Syndrome in China: Balloon Angioplasty Alone or Combined With Stent Placement?RecruitingNo Results AvailableBudd-Chiari SyndromeDevice: Stent|Device: Balloonhttps://ClinicalTrials.gov/show/NCT02201485
2776627766Magnetic Resonance Elastography in InfantsEnrolling by invitationNo Results AvailableLiver DiseaseDevice: MRI with MREhttps://ClinicalTrials.gov/show/NCT02201472
2776727767Nilotinib ± Peg-IFN for First Line Chronic Phase CML PatientsRecruitingNo Results AvailableChronic Myeloid LeukemiaDrug: Nilotinib (Tasigna ®), capsules of 150 mg|Drug: Nilotinib (Tasigna ®) and Pegylated interferon alfa 2a (Pegasys®)https://ClinicalTrials.gov/show/NCT02201459
2776827768The Role of Circulating Soluble CD74 in Acute Lung InjuryRecruitingNo Results AvailableAcute Lung Injury|Acute Respiratory Distress Syndrome|Biomarker|Lung|Inflammationhttps://ClinicalTrials.gov/show/NCT02201446
2776927769Study on the Treatment of Children and Their Families in Services Related to Early ChildhoodRecruitingNo Results AvailableFathers|Premature Birthhttps://ClinicalTrials.gov/show/NCT02201433
2777027770Evaluation of Technetium Tc 99m Tilmanocept (Lymphoseek®) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage From KS Lesions by SPECT and SPECT/CT ImagingCompletedNo Results AvailableKaposi's SarcomaDrug: Tc 99m tilmanocepthttps://ClinicalTrials.gov/show/NCT02201420
2777127771An Open-Label, Multicenter, National Observational Study in Patients With Chronic Hepatitis B Receiving Therapy With PEGASYS (Peginterferon Alfa-2a 40kD) - The PRO B StudyRecruitingNo Results AvailableHepatitis B, Chronichttps://ClinicalTrials.gov/show/NCT02201407
2777227772Reversing Ticagrelor's Effects With Fresh PlateletsRecruitingNo Results AvailableCoronary Artery DiseaseDrug: Loading dose|Drug: Loading dose|Drug: Maintenance dose|Drug: Maintenance dosehttps://ClinicalTrials.gov/show/NCT02201394
2777327773Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on CancerSuspendedNo Results AvailableCancer|Quality of Lifehttps://ClinicalTrials.gov/show/NCT02201381
2777427774Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation DefectsWithdrawnNo Results AvailableLong-chain Fatty Acid Transport DeficiencyDrug: Triheptanoin (SpezialölÒ 107®)|Dietary Supplement: MCT (Medium-Chain Triglycerides)https://ClinicalTrials.gov/show/NCT02201368
2777527775Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and NeckRecruitingNo Results AvailableSquamous Cell Carcinoma of the Head and Neck T1/2N0-2Radiation: Intensity Modulated Radiotherapyhttps://ClinicalTrials.gov/show/NCT02201355
2777627776Pharmacokinetic/Pharmacodynamic Study of Udenafil in AdolescentsCompletedNo Results AvailableSingle Ventricle Heart Disease After Fontan SurgeryDrug: Udenafilhttps://ClinicalTrials.gov/show/NCT02201342
2777727777Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaActive, not recruitingNo Results AvailableMyelodysplastic Syndromes|Leukemia, Myelomonocytic, ChronicDrug: Azacitidine|Drug: Volasertibhttps://ClinicalTrials.gov/show/NCT02201329
2777827778A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTINâ„¢) in Healthy Adult Human Subjects Under Fasting ConditionsCompletedNo Results AvailableGastritisDrug: Reference mosapride citrate (GASMOTIN)|Drug: GR107719B (Formulation 1)|Drug: GR107719B (Formulation 2)https://ClinicalTrials.gov/show/NCT02201316
2777927779Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface ExpressionCompletedNo Results AvailableInfections, Respiratory Syncytial VirusDrug: Danirixin|Other: CXCL1https://ClinicalTrials.gov/show/NCT02201303
2778027780A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)RecruitingNo Results AvailablePurpura, Thrombocytopenic, IdiopathicDrug: Eltrombopag Tablets|Drug: Eltrombopag PfOShttps://ClinicalTrials.gov/show/NCT02201290

* Görseller ve İçerik tekif hakkına sahip olabilir